NCT05345808

Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: Al-Azhar University · Academic / Other
• Sex: All
• Age: 50 Years – 69 Years
• Healthy volunteers: Not accepted

Summary

Retinal vein occlusion (RVO) is considered the second vascular disorder of the retina after diabetic retinopathy. Patients with RVO are at risk of the development of macular edema. Different treatment modalities for macular edema include LASER therapy, antivascular endothelial growth factor (VEGF), and triamcinolone. Aim To detect the efficacy of formulated Triamcinolone Acetonide(TA) injection in the posterior subtenon space to manage macular edema secondary to non-ischemic RVOs, either central or branch.

Conditions

• Retinal Vein Occlusion

Interventions

Type	Name	Description
DRUG	Triamcinolone Acetonide	Triamcinolone Acetonide formulated with chondroitin sulfate and sodium hyaluronate

Timeline

• Start date: 2021-03-01
• Primary completion: 2022-02-20
• Completion: 2022-03-30
• First posted: 2022-04-26
• Last updated: 2022-04-26

Locations

1 site across 1 country: Egypt